A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
- López-Jaramillo, P.
- Pradilla, L.P.
- Lahera, V.
- Silva Sieger, F.A.
- Rueda-Clausen, C.F.
- Márquez, G.A.
Revista:
Trials
ISSN: 1745-6215, 1745-6215
Año de publicación: 2006
Volumen: 7
Tipo: Artículo